by Providertech | Jun 23, 2021 | Patient Communication, Patient Engagement, Patient Outreach, Population Health
Most physician practices in the United States have put their COVID-19- financial woes behind them. A recent survey notes that roughly 90 percent of practices are conducting chronic care follow-up and screening patients for depression or anxiety, while about 80 percent...
by Providertech | May 25, 2021 | Automation, Patient Access, Patient Communication, Population Health
The age of artificial intelligence (AI) technology is already upon us, taking over a vast majority of tasks that were once performed by us humans alone. As a matter of fact, we already make use of this state-of-the-art tech innovation nearly every day when we talk...
by Providertech | May 11, 2021 | Patient Access, Patient Communication, Patient Engagement, Patient Outreach, Population Health, Uncategorized
As of the beginning of May, 105 million Americans (31.9 percent of the total population) are fully vaccinated, and 147 million United States residents (44.8 percent of the total population) have received at least one dose of one of the three approved COVID-19...
by Providertech | Apr 14, 2021 | Patient Access, Patient Engagement, Population Health, Uncategorized
Lung cancer is the second most common type of cancer and the leading cause of cancer death in the United States. Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. Although the primary risk factor for lung cancer is...
by Providertech | Apr 6, 2021 | Patient Communication, Patient Engagement, Patient Outreach, Population Health
Chronic disease can be regarded as a major and persistent epidemic of our time. Today, roughly 40 million people in the United States are restricted in their day-to-day activities due to one or more common chronic health conditions. The most widespread chronic...
by Lisa Blue | Mar 23, 2021 | Patient Communication, Patient Engagement, Patient Outreach, Population Health
It’s been approximately three months since the first COVID-19 vaccine received emergency use authorization (EUA) in the United States. On December 11, the U.S. Food and Drug Administration announced that the Pfizer-BioNTech coronavirus vaccine was available for most...
